355 related articles for article (PubMed ID: 15990020)
41. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
Ryk C; Kumar R; Thirumaran RK; Hou SM
Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
[TBL] [Abstract][Full Text] [Related]
43. Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations.
Kiuru A; Lindholm C; Heilimo I; Ceppi M; Koivistoinen A; Ilus T; Hirvonen A; Norppa H; Salomaa S
Environ Mol Mutagen; 2005 Oct; 46(3):198-205. PubMed ID: 15971256
[TBL] [Abstract][Full Text] [Related]
44. Unexpectedly severe acute radiotherapy side effects are associated with single nucleotide polymorphisms of the melanocortin-1 receptor.
Fogarty GB; Muddle R; Sprung CN; Chen W; Duffy D; Sturm RA; McKay MJ
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1486-92. PubMed ID: 19932942
[TBL] [Abstract][Full Text] [Related]
45. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer.
Moreno V; Gemignani F; Landi S; Gioia-Patricola L; Chabrier A; Blanco I; González S; Guino E; Capellà G; Canzian F
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2101-8. PubMed ID: 16609022
[TBL] [Abstract][Full Text] [Related]
47. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
48. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.
Chung HH; Kim MK; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2006 Dec; 103(3):1031-7. PubMed ID: 16875718
[TBL] [Abstract][Full Text] [Related]
49. XRCC1 Arg399Gln genetic polymorphism in a Turkish population.
Kocabaş NA; Karahalil B
Int J Toxicol; 2006; 25(5):419-22. PubMed ID: 16940014
[TBL] [Abstract][Full Text] [Related]
50. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
52. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants.
Kornguth DG; Garden AS; Zheng Y; Dahlstrom KR; Wei Q; Sturgis EM
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):665-71. PubMed ID: 15936543
[TBL] [Abstract][Full Text] [Related]
53. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
[TBL] [Abstract][Full Text] [Related]
54. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
55. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
56. X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas.
Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
Cancer; 2007 Jul; 110(2):318-25. PubMed ID: 17559126
[TBL] [Abstract][Full Text] [Related]
57. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
Stern MC; Siegmund KD; Conti DV; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2384-90. PubMed ID: 17164360
[TBL] [Abstract][Full Text] [Related]
58. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.
Yen CY; Liu SY; Chen CH; Tseng HF; Chuang LY; Yang CH; Lin YC; Wen CH; Chiang WF; Ho CH; Chen HC; Wang ST; Lin CW; Chang HW
J Oral Pathol Med; 2008 May; 37(5):271-7. PubMed ID: 18410587
[TBL] [Abstract][Full Text] [Related]
59. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.
Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW
Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133
[TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus.
Loizidou MA; Michael T; Neuhausen SL; Newbold RF; Marcou Y; Kakouri E; Daniel M; Papadopoulos P; Malas S; Kyriacou K; Hadjisavvas A
Breast Cancer Res Treat; 2008 Dec; 112(3):575-9. PubMed ID: 18188695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
